26th-Jun-2006 14:38Source: BSE

Yes Bank Ltd (Manager to the Offer) has informed BSE that the offer for physical shareholders in the Voluntary Delisting of Shares of Merven Drug Products Ltd (New Name "Arch Pharmalabs Ltd") (Target ...

12th-Jun-2006 18:16Source: BSE

Yes Bank Ltd ("Manager to the Offer"), on behalf of Arch Impex Pvt Ltd ("Acquirer") has issued this Public Announcement ("PA") to the equity shareholders of Merven Drug Products Ltd (New Name "Arch Ph...

26th-May-2006 16:58Source: BSE

Yes Bank Ltd ("Manager to the Offer"), on behalf of Arch Impex Pvt Ltd ("Acquirer") has issued this Public Announcement ("PA") in respect of the proposed acquisition and delisting of the equity shares...

26th-Apr-2006 19:05Source: BSE

Merven Drug Products Ltd has informed BSE that Company will publish the audited financial results for the accounting year (2004-05) ended on March 31, 2006 before June 30, 2006. Hence, the unaudite...

13th-Dec-2005 16:02Source: BSE

Merven Drug Products Ltd has informed BSE that the members at the 12th Annual General Meeting (AGM) of the Company held on December 09, 2005, inter alia, have passed the following resolutions: 1. A...

17th-Nov-2005 16:38Source: BSE

Merven Drug Products Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 06, 2005 to December 09, 2005 (both days inclusive) for th...

21st-Oct-2005 18:24Source: BSE

Merven Drug Products Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 28, 2005, inter alia, to consider: 1. Approve and Adopt the Unaudited Finan...

19th-Sep-2005 09:55Source: BSE

Merven Drug Products Ltd has informed BSE that pursuant to the Company’s application made to the Registrar of Companies, Maharashtra on September 05, 2005 for extension of time period for convening th...

4th-Aug-2005 09:12Source: BSE

Merven Drug Products Ltd has informed BSE that the Company is in receipt of a letter from Swiss Technology Venture Capital Funds Pvt. Ltd, Mauritius dated July 26, 2005, requesting the Company to conv...

31st-Mar-2005 16:49Source: BSE

Merven Drug Products Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 31, 2005, inter alia, has allotted the following securities: 1. Fully paid-up 16,00...